These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2013 Aug 30; 62(34):685-93. PubMed ID: 23985496 [Abstract] [Full Text] [Related]
13. National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2023. Pingali C, Yankey D, Chen M, Elam-Evans LD, Markowitz LE, DeSisto CL, Schillie SF, Hughes M, Valier MR, Stokley S, Singleton JA. MMWR Morb Mortal Wkly Rep; 2024 Aug 22; 73(33):708-714. PubMed ID: 39173168 [Abstract] [Full Text] [Related]
14. Overcoming barriers to adolescent vaccination: perspectives from vaccine providers in North Carolina. Vielot NA, Islam JY, Sanusi B, Myers J, Smith S, Meadows B, Brewer NT, Smith JS. Women Health; 2020 Aug 22; 60(10):1129-1140. PubMed ID: 32772834 [Abstract] [Full Text] [Related]
15. Vaccination coverage among adolescents aged 13-17 years - United States, 2007. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2008 Oct 10; 57(40):1100-3. PubMed ID: 18846032 [Abstract] [Full Text] [Related]
18. MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial. Rivera L, Chanthavanich P, Põder A, Suryakiran PV, Jastorff A, Van der Wielen M. Vaccine; 2018 Jun 22; 36(27):3967-3975. PubMed ID: 29789243 [Abstract] [Full Text] [Related]